key: cord-0794268-5z1r1860
authors: Manabe, Yukari C; Reuland, Carolyn; Yu, Tong; Azamfirei, Razvan; Hardick, Justin P; Church, Taylor; Brown, Diane M; Sewell, Thelio T; Antar, Annuka; Blair, Paul W; Heaney, Chris D; Pekosz, Andrew; Thomas, David L
title: Self-collected oral fluid saliva is insensitive compared to nasal-oropharyngeal swabs in the detection of SARS-CoV-2 in outpatients
date: 2020-12-30
journal: Open Forum Infect Dis
DOI: 10.1093/ofid/ofaa648
sha: 7b97431e230985f39bb4b34fbabdcb44dd819666
doc_id: 794268
cord_uid: 5z1r1860

SARS-CoV-2 pandemic control will require widespread access to accurate diagnostics. Salivary sampling circumvents swab supply chain bottlenecks, is amenable to self-collection, and is less likely to create an aerosol during collection compared to the nasopharyngeal swab. We compared rRT-PCR Abbott m2000 results from matched salivary oral fluid (gingival crevicular fluid collected in an Oracol device) and nasal-oropharyngeal (OP) self-collected specimens in viral transport media from a non-hospitalized, ambulatory cohort of COVID-19 patients at multiple time points. There were 171 matched specimen pairs. Compared to nasal-OP swabs, 41.6% of the oral fluid samples were positive. Adding spit to the oral fluid collection device increased the percent positive agreement from 37.2% (16/43) to 44.6% (29/65). The percent positive agreement was highest in the first 5 days after symptoms and decreased thereafter. All of the infectious nasal-OP samples (culture positive on VeroE6 TMPRSS2 cells) had a matched SARS-CoV-2 positive oral fluid sample. In this study of non-hospitalized SARS-CoV-2 infected persons, we demonstrate lower diagnostic sensitivity of self-collected oral fluid compared to nasal-OP specimens, a difference that was especially prominent more than 5 days from symptom onset. These data do not justify the routine use of oral fluid collection for diagnosis of SARS-CoV-2 despite the greater ease of collection. It also underscores the importance of considering the method of saliva specimen collection, and the time from symptom onset especially in outpatient populations.

The COVID-19 pandemic caused by the SARS-CoV-2 virus has rapidly spread globally and resulted in significant morbidity and mortality.

[1] The rapid transmission of SARS-CoV-2 has focused unprecedented attention on the importance of diagnostics that are both accurate and widely available for pandemic control. [2, 3] While attention is often given to the diagnostic platform, the specimen collection methods are also important determinants of accuracy and availability. For molecular amplification assays, nasopharyngeal (NP) specimen collection using flocked swabs has the highest sensitivity [4] . However, there is an urgent need to replace the NP specimen type as swab supplies are limited, and the procedure is uncomfortable. Alternate sample types [5] including saliva have been used to detect SARS-CoV-2. [6] [7] [8] Importantly, there are multiple sample types that may be called "saliva" in the literature; spit and passive drool (no material from the posterior pharynx is included), oral crevicular fluid (a sponge rubbed against the gingival crevice releasing oral fluid rich in antibodies), and expectorated spit/sputum. A review of the literature of these sample types compared against an NP molecular test qualitative gold standard is presented in Table 1 with a Forest plot of the proportion positive agreement Figure 1 . In many studies, saliva specimens have lower proportion positive agreement, but conversely, saliva often detected SARS-CoV-2 when the NP swab was negative in a proportion of the samples thereby decreasing proportion negative agreement as well. Salivary sampling circumvents swab supply chain bottlenecks, simplifies self-collection even by children, and reduces aerosolization during collection. A few studies have also suggested salivary sampling has high diagnostic sensitivity. (9) In one hospitalized cohort of matched NP swab and saliva specimens, saliva specimens had higher mean log copies per milliliter of SARS-CoV-2 RNA than NP swab specimens.(6) However, the advantage of salivary collection is even greater in outpatient settings. Thus, in a cohort of ambulatory COVID-19 adults, we compared SARS-CoV-2 RNA detection and abundance in a longitudinal series of self-collected and matched oral fluid saliva and upper respiratory (nasal-oropharyngeal) specimens utilizing the M a n u s c r i p t Abbott Molecular RealTime SARS-CoV-2 assay followed by cell culture of RNA positive samples. We sought to understand the sensitivity of the oral fluid saliva sample type over time in ambulatory COVID-19 patients.

From April 21-July 16, 2020, non-hospitalized adults who were self-isolating after receiving a positive NP SARS-CoV-2 rRT-PCR result from the Johns Hopkins Medical Microbiology laboratory were approached for participation by telephone using a verbal consent script.

Inclusion criteria were age >18 years, able to receive study materials while remaining in isolation and able and willing to perform self-collection of specimens. Participants who were able to give an oral informed consent after documentation of understanding were enrolled in the study. [9] This study was approved by the Institutional Review Board of the Johns Hopkins University School of Medicine.

Participants were mailed a sample collection kit which included an international air transport association (IATA) approved biologic sample container as well as sample collection materials and written instructions for sample collection. Additionally, study coordinators provided verbal sample collection instructions and observed participants by video call when possible. The study coordinators recorded their assessment of the quality of self-collection.

Participants self-collected mid-turbinate nasal and oropharyngeal (nasal-OP) swabs; both swabs were placed in 3ml viral transport medium (VTM, 11). Self-collected samples have been previously validated and published. [10] [11] [12] By placing them in the same media, this combination aimed to optimize detection and approximated the NP clinician-collected sample. [13] Participants also collected oral crevicular saliva fluid via the Oracol saliva collection system (oral fluid) (Malvern Medical Developments Ltd., Worchestershire, UK), a transport buffer-free sample collection system. All samples were immediately placed in the A c c e p t e d M a n u s c r i p t IATA container and stored in the participant"s freezer prior to shipping. Participants selfcollected samples on the day they received the collection materials (day 0), and then subsequently on study days 3, 7, 14. On day 14, the participant shipped the collected samples on cold packs to Johns Hopkins University for analysis using an overnight courier service. A final in-person collection occurred between day 28-60 when a clinician-collected NP swab and a self-collected Oracol was performed. Participants were instructed to open and remove the saliva collection sponge from the device container, rub their gums for 1-2 minutes with the sponge, then reinsert the swab back into the device container and closes the container. This collection method targets gingival crevicular fluid, which leaks from the space between the gums and teeth and is enriched with IgG antibodies derived from blood.

Based on publication of the spit saliva sample type [14] , participants were instructed to spit one time into the Oracol after gum collection from June 1, 2020 onward. Clinical information was collected using a standardized Flu-PRO [15] instrument on the same days as sample collection, in addition to patient history in a predesigned database.

The nasal-OP swab VTM was aliquoted into multi-Collect tubes (Abbott Molecular, Des Plaines, Il) in 600 µl volumes prior to testing with the Abbott Molecular RealTime SARS-CoV-2 assay. Nucleic acid was extracted from the multi-Collect tubes utilizing the Abbott 

Of the 118 participants enrolled that were previously described [9] , 71 participants had at Table 1) .

We cultured all rRT-PCR positive nasal-OP specimens on VeroE6 TMPRSS2 cells. All culture positive samples (n=16) were obtained within 11 days of symptom onset. In all matched samples in which SARS-CoV-2 was culture positive (n=9), SARS-CoV-2 RNA was detected by rRT-PCR in both nasal-OP and oral fluid samples.

In this investigation of non-hospitalized SARS-CoV-2 infected persons, we demonstrate lower diagnostic sensitivity of self-collected oral fluid compared to nasal-OP specimens, a difference that was especially prominent more than 5 days from symptom onset. These data [14, 29] It remains unclear whether differences in diagnostic yield for saliva versus nasal-OP reflect shifts in SARS-CoV-2 replication from upper to lower respiratory tissues. Nonetheless, the timing of collection, time after onset of symptoms, hospitalized vs outpatient populations, and the volume of saliva/spit may all be important for optimizing diagnostic sensitivity, and device manufacturers will need to consider these factors when considering what sample types to test and when assessing assay performance.

Overall, most studies of spit or passive drool reveal a lower sensitivity compared to NP, but identify cases missed by the NP sample type.

While SARS-CoV-2 testing is chiefly used for diagnostics, it has also been used to assess infectivity. In our experience using culture as a gold standard for infectivity, both collection methods were equivalent in their ability to identify patients with infectious virus; all those whose nasal-OP sample was cultured were rRT-PCR positive in both sample types.

Our paper has some important limitations. Because all participants were enrolled on the basis of a clinician-collected NP swab, this may bias against saliva sample types; if saliva is more sensitive early in infection, any participant who was initially saliva positive and NP negative would not have had the opportunity to enroll. In addition, 200ul of neat saliva was assayed compared to 600ul of nasal-OP swab VTM (from a total volume of 3ml). It is possible that if a concentration capture method were applied to saliva, yields for this sample type may improve sensitivity. Based on the enrollment strategy to follow ambulatory participants, we collected specimens from when participants were enrolled. Therefore, the number of days after symptoms varied; those that were within the first 5 days of symptoms, when oral fluid with spit was most sensitive were limited. Finally, although self-collected samples have been shown by others to be equally sensitive, Kojima et al. found that unsupervised self-collected oral fluid had lower sensitivity. [12] In our study, participants were coached by phone or facetime and the presence of human DNA in the sample verified.

Nonetheless, self-collection may have contributed to variability.

A c c e p t e d M a n u s c r i p t

In summary, in what we believe may be the largest ambulatory study of its kind, we detected lower SARS-CoV-2 yield in oral fluid compared to nasal-OP specimens, and improvements in oral fluid enriched with spit. Differences in net diagnostic sensitivity were especially notable more than 5 days after symptom onset. These results are significant since more than 80% of COVID-19 and nearly all the initial diagnostics are in ambulatory persons. Thus, while our data and others demonstrate the potential pragmatic use of salivary samples to detect SARS-CoV-2 [30], they also underscore the importance of carefully considering the source of specimens and possibly time from symptom onset, especially for home detection systems.

A c c e p t e d M a n u s c r i p t A c c e p t e d M a n u s c r i p t

Due to the contagious nature of COVID-19 being studied under this protocol, obtaining signed informed consent form for subjects enrolled in this study was not feasible or safe initially for study staff. Instead, the study staff obtained a verbal consent using consent waiver with an alteration of the informed consent. All participants provided verbal consent after documentation of understanding as they were self-isolating at home due to COVID-19 according to a consent script that was provided in either English or Spanish. A copy of the A c c e p t e d M a n u s c r i p t M a n u s c r i p t M a n u s c r i p t

An interactive web-based dashboard to track COVID-19 in real time

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

The Need for More and Better Testing for COVID-19

Comparison of flocked and rayon swabs for collection of respiratory epithelial cells from uninfected volunteers and symptomatic patients

Journal of clinical virology : the official publication of the Pan American Society for

Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study

Detection profile of SARS-CoV-2 using RT-PCR in different types of clinical specimens: A systematic review and metaanalysis

SARS-CoV-2, SARS-CoV-1 and MERS-CoV viral load dynamics, duration of viral shedding and infectiousness: a living systematic review and meta-analysis. medRxiv : the preprint server for health sciences

The clinical course of COVID-19 in the outpatient setting: a prospective cohort study. medRxiv : the preprint server for health sciences

Comparison of Unsupervised Home Selfcollected Midnasal Swabs With Clinician-Collected Nasopharyngeal Swabs for Detection of SARS-CoV-2 Infection

Assessment of Sensitivity and Specificity of Patient-Collected Lower Nasal Specimens for Severe Acute Respiratory Syndrome Coronavirus 2 Testing

Self-Collected Oral Fluid and Nasal Swab Specimens Demonstrate Comparable Sensitivity to Clinician-Collected Nasopharyngeal Swab Specimens for the Detection of SARS-CoV-2

Self-Collected Anterior Nasal and Saliva Specimens versus Healthcare Worker-Collected Nasopharyngeal Swabs for the Molecular Detection of SARS-CoV-2

Saliva is more sensitive for SARS-CoV-2 detection in COVID-19 patients than nasopharyngeal swabs. medRxiv : the preprint server for health sciences

Development of the Flu-PRO: a patientreported outcome (PRO) instrument to evaluate symptoms of influenza

Saliva as a potential clinical specimen for diagnosis of SARS-CoV-2. medRxiv : the preprint server for health sciences

Saliva offers a sensitive, specific and noninvasive alternative to upper respiratory swabs for SARS-CoV-2 diagnosis. medRxiv : the preprint server for health sciences

Salivary Detection of COVID-19

Does sampling saliva increase detection of SARS-CoV-2 by RT-PCR? Comparing saliva with oro-nasopharyngeal swabs. medRxiv : the preprint server for health sciences

Comparison of SARS-CoV-2 detection in nasopharyngeal swab and saliva

Sensitivity of nasopharyngeal swabs and saliva for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Validation of self-collected buccal swab and saliva as a diagnostic tool for COVID-19. medRxiv : the preprint server for health sciences

Saliva as an Alternate Specimen Source for Detection of SARS-CoV-2 in Symptomatic Patients Using Cepheid Xpert Xpress SARS-CoV-2

Saliva sampling for diagnosing SARS-CoV-2 infections in symptomatic patients and asymptomatic carriers

Prospective comparison of saliva and nasopharyngeal swab sampling for mass screening for COVID-19. medRxiv : the preprint server for health sciences

Clinical Evaluation of Self-Collected Saliva by Quantitative Reverse Transcription-PCR (RT-qPCR), Direct RT-qPCR, Reverse Transcription-Loop-Mediated Isothermal Amplification, and a Rapid Antigen Test To Diagnose COVID-19

Saliva sample pooling for the detection of SARS-CoV-2

Comparative evaluation of nasopharyngeal swab and saliva specimens for the molecular detection of SARS-CoV-2 RNA in Japanese patients with COVID-19

Evaluation of symptomatic patient saliva as a sample type for the Abbott ID NOW COVID-19 assay. medRxiv : the preprint server for health sciences

Validation of Saliva and Self-Administered Nasal Swabs for COVID-19 Testing. medRxiv : the preprint server for health sciences

Saliva as a Noninvasive Specimen for Detection of SARS-CoV-2

Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2

Saliva is a promising alternative specimen for the detection of SARS-CoV-2 in children and adults. medRxiv : the preprint server for health sciences

SARS-CoV-2 identification and IgA antibodies in saliva: One sample two tests approach for diagnosis

Performance of At-Home Self-Collected Saliva and Nasal-Oropharyngeal Swabs in the Surveillance of COVID-19. medRxiv : the preprint server for health sciences

Self-Collected Oral Fluid and Nasal Swabs Demonstrate Comparable Sensitivity to Clinician Collected Nasopharyngeal Swabs for Covid-19 Detection. medRxiv : the preprint server for health sciences

Posterior oropharyngeal saliva for the detection of SARS-CoV-2. medRxiv : the preprint server for health sciences

A Direct Comparison of Enhanced Saliva to Nasopharyngeal Swab for the Detection of SARS-CoV-2 in Symptomatic Patients

Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study

A c c e p t e d M a n u s c r i p t A c c e p t e d M a n u s c r i p t A c c e p t e d M a n u s c r i p t A c c e p t e d M a n u s c r i p t A c c e p t e d M a n u s c r i p t